Gene Query: SUV39H1

Dataset Description Geneva Score
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq II) 434.53
Survival of pancreatic cancer cells lacking KRAS function 24.87
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 23.04
MOF acetyl transferase regulates transcription and respiration in mitochondria 17.82
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 12.69
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 11.79
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 11.79
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 11.69
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 10.56
A transcriptome-wide divergence in protein translation scales with LIN28B expression 10.02
Co-transcriptional loading of RNA export factors shapes the human transcriptome 9.57
RNAseq of HEK293 cells after Chtop knockdown 9.57
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 9.4
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 9.4
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 9.25
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 9.25
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 9.22
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 8.9
Effect of drugs on transcriptomic profiles 8.85
snRNAs as regulators of alternative splicing 8.77
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 8.69
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 8.69
U1 snRNP telescripting regulates size-function stratified human genome 8.28
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 8.26
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 8.05
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 7.86
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 7.72
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 7.53
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 7.48
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 7.31
Silencing p300 in MCF7 cells to study expression and alternative splicing 7.26
Gene expression analysis of the impact of TDP-43 knockout in human cells. 7.15
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 6.92
Differential gene expression of human melanoma cells [RNA-seq] 6.74
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 6.74
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 6.63
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 6.63
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 6.55
SUV420H2 knockdown in PANC-1 6.54
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 6.53
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 6.52
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 6.33
Seletive inhibition of CDK9 in DLBCL cell lines 6.31
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 6.16
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 6.08
Regulation of protein translation during mitosis 6.07
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 6.02
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 5.98
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 5.94
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 5.94
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 5.92
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 5.87
A549 cells and MSR-A549 cells 5.86
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 5.86
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 5.83
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 5.74
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 5.73
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.71
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 5.7
MYCi361 regulates MYC target genes 5.67
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 5.55
Effect of Hotair overexpression in human breast cancer cell lines 5.48
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 5.41
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 5.34
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.31
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 5.25
Global gene expression profile of dasatinib-resistant RCH-ACV cells 5.22
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 5.17
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 5.14
Accurate annotation of human protein-coding small open reading frames 5.13
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 5.07
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 5.01
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 4.99
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 4.99
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 4.92
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 4.87
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 4.85
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.85
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 4.62
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 4.62
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 4.6
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 4.55
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 4.55
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 4.52
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 4.52
RNA-seq of cancer cell lines treated with T-025 4.51
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 4.46
Effect of PRDM11 depletion in U2932 cells 4.43
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.38
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 4.35
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 4.34
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 4.31
Transcription control by the ENL YEATS domain in acute leukemia 4.3
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 4.3
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 4.26
The regulartory role of ZCCHC24 in splicing machinery 4.23
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 4.2
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 4.19
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 4.14
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 4.11
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 4.1
Global analysis of alternative splicing regulated by RBM10 4.04
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 4.01
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 4.0
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 4.0
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 3.95
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 3.95
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 3.89
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 3.84
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 3.83
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 3.83
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 3.82
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 3.81
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 3.81
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 3.8
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 3.8
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.79
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.79
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 3.76
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 3.74
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 3.73
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 3.73
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.71
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 3.67
Loss of CREBBP results in gene expression repression in lymphoma cells 3.67
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.67
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 3.65
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 3.64
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.61
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.61
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 3.56
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 3.56
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 3.54
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 3.53
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 3.51
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.51
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 3.46
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 3.46
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 3.46
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 3.43
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.41
RNA-seq of shEZH2 cells 3.41
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 3.36
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 3.35
Transcriptional responses of human insulinoma cells to acute cytokine exposure 3.35
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 3.35
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.34
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 3.31
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 3.3
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 3.3
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 3.3
Ribosomal protein RPL26 is the principal target of UFMylation 3.3
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 3.29
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 3.26
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 3.25
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 3.25
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 3.24
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 3.21
Genome wide expression change in LCC2 and MCF-7 cells 3.2
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 3.19
The role of FAM46C in myeloma cells 3.18
The role of FAM46C in myeloma cells [sequencing] 3.18
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 3.16
Total RNA-seq in ALL-SIL upon JQ1 inhibition 3.16
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 3.15
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 3.14
In situ CAPTURE of chromatin interactions by biotinylated dCas9 3.11
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 3.11
Genome-wide analysis of Dengue virus 2 infected cells 3.1
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 3.09
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 3.09
Effect of CHKA knockdown on C4-2 cell transcriptome 3.08
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 3.06
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 3.06
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 3.04
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 3.02
Gene expression profiling of leukemia cells following asparagine depletion 3.0
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 2.99
Altering cancer transcriptomes using epigenomic inhibitors 2.97
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 2.97
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 2.95
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.92
RNA splicing alteration on glioblastoma and normal neural stem cells 2.91
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 2.91
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 2.91
The landscape of alternative splicing in aggressive prostate cancers 2.89
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 2.89
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 2.89
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 2.88
Effect of FGF13 depletion on the H460 cell line 2.88
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 2.87
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 2.87
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 2.87
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 2.83
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 2.82
Transcriptome-wide identification of CELF2 functional targets in T cells 2.81
Modulation of nonsense-mediated decay by rapamycin 2.79
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.78
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 2.77
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 2.76
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.71
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 2.7
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.67
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 2.67
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.66
Tracking of dCas9-methyltransferase footprints 2.65
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 2.64
Identification of global regulators of T-helper cell lineage specification 2.64
RNAseq Study in CC-671 Treated Cal-51 Cells 2.64
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 2.64
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.64
Impact of dieldrin on transcription in Jurkat T cells 2.63
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 2.63
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 2.62
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 2.62
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 2.61
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 2.58
RNA expression analysis upon JMJD1C depletion 2.58
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.58
NR2F2 study 2.58
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 2.58
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 2.56
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 2.53
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 2.53
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 2.52
Expression and functions of long noncoding RNAs during human T helper cell differentiation 2.51
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 2.5
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 2.5
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 2.5
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.48
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 2.48
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 2.47
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 2.46
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 2.46
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.44
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 2.44
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 2.44
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.43
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 2.43
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.41
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 2.4
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 2.39
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 2.38
RNA-seq of resting and activated CD4+ T cells +-JQ1 2.38
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.38
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.36
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.36
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 2.36
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 2.35
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.34
IRF2 is a master regulator of human keratinocyte stem cell fate 2.33
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 2.33
Role of XRN2 ribonucleolytic activity in RNA metabolism 2.32
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 2.3
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 2.3
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 2.29
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 2.29
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.26
Dynamic 3D chromosomal landscapes in acute leukemia 2.26
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 2.26
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 2.25
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 2.25
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.22
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.22
PRDM1 inhibits proliferation of human colon cancer organoids 2.2
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.16
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.15
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 2.15
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 2.15
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 2.15
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 2.14
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.13
BACH2 in human plasma cell fate decision 2.1
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.1
Bone marrow derived human B cells [normal proB] 2.1
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 2.09
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 2.09
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 2.08
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.05
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 2.04
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.03
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.03
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.03
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.99
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.99
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.97
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.97
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 1.97
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 1.97
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 1.97
Next Generation Sequencing of human SMA and healthy control Motor Neurons 1.95
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.95
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.94
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 1.93
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.93
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 1.92
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.92
EWSR1 influences alternative splicing through direct and indirect mechanisms 1.91
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.89
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 1.89
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.88
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.88
Microprocessor mediates transcription termination in long noncoding microRNA genes 1.86
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 1.85
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 1.85
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 1.85
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 1.84
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 1.83
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 1.79
FBXW7 modulates stress response by post-translational modification of HSF1 1.79
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 1.79
Ribosome profiling upon inhibition of eIF4A 1.77
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.77
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 1.76
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 1.75
Transcriptional profiling of LS1034 cells treated with tepoxalin 1.74
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.73
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.73
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.72
The Genetic Landscape of Diamond-Blackfan Anemia 1.69
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.69
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.68
Spliceosomal disruption of the non-canonical BAF complex in cancer 1.66
A map of gene expression in neutrophil-like cell lines 1.65
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.65
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 1.64
Regulation of poly(A) tail and translation during the somatic cell cycle 1.63
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.62
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 1.6
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.59
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.56
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.56
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 1.55
PTHrP overexpression in MCF7 cells 1.54
Differential Protein Occupancy Profiling of the mRNA Transcriptome 1.53
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.51
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.51
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.5
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.5
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 1.49
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 1.49
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.46
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 1.45
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 1.45
Functional significance of the HIV-1 Tat signature amino acid residues 1.45
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 1.45
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 1.45
m6A-dependent regulation of messenger RNA stability 1.43
Effect of from Human Umbilical Vein Endothelial Cells 1.43
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.43
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.42
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.39
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.39
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 1.38
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 1.38
Co-regulation of splicing by Rbfox1 and hnRNP M 1.38
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 1.38
Identification of a LIF-responsive replication-competent human β cell 1.37
RNA-seq analysis of uveal melanoma cells treated with FR900359 1.33
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.31
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 1.29
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.29
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 1.27
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 1.27
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 1.26
Comparative Analysis of Cas9 Activators Across Multiple Species 1.26
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.26
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.21
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 1.21
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 1.2
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.19
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.19
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.19
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.19
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 1.15
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.15
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.15
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 1.15
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 1.15
Transcriptome analysis of SKI knock-out in HL60 cells 1.13
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 1.13
Determining mRNA half-lives on a transcriptome-wide scale 1.12
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.11
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.09
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 1.08
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.08
The cohesin complex prevents Myc-induced replication stress 1.07
K562 polyA RNA-Seq 1.06
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 1.06
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.06
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 1.06
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 1.01
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.0
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 0.98
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.97
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.97
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.96
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 0.96
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.95
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.93
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 0.9
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.9
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 0.9
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 0.9
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.88
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 0.86
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 0.85
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.85
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 0.84
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 0.84
Illumina Total RNA-seq in HeLa 0.84
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.83
Ro60-knockout cells 0.83
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.82
Gene expression profile of multiple myeloma cell lines treated with CB-5083 0.77
Transcriptome sequencing of K-562 cells 0.77
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.75
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.73
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 0.73
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 0.72
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.72
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.72
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.72
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.71
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.71
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.71
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.71
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.7
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.7
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.69
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.69
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.69
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.68
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.65
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.64
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.63
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.62
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.6
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.58
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.58
RNA-seq analysis upon ARID1B overexpression 0.58
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.56
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.54
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 0.54
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.54
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.53
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.52
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.51
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.51
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.51
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.5
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.46
RNA-seq analysis of differentiating human erythroblasts 0.44
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.43
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 0.42
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 0.42
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.42
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.4
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.39
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.38
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.37
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.36
MicroRNA-125a-5p overexpression in human macrophages 0.36
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.34
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.34
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.31
Gene expression profile of CRC-derived HILEC 0.3
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.27
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.26
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.26
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.25
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 0.24
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.24
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.23
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.2
RNA-Seq of PRMT1 overexpression ECA109 cells 0.19
The role of m6A/m-RNA methylation in stress response regulation 0.19
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.19
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.17
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.15
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.15
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.14
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.14
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 0.14
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.14
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.13
Gene expression analysis upon mtDNA depletion 0.12
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.12
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.11
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.11
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.07
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.05
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.04
Function and hormonal regulation of GATA3 in human first trimester placentation 0.04
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.03
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.03
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.03
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 0.03
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.02
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation